On Demand 2019 Evolution of Food Allergy Therapies (MOC)

Price: $25 members, $35 non-members

Several new interventions are likely to be approved by the FDA in the upcoming year. These therapies have different levels of efficacy and side effects and will likely greatly impact office flow. Thus, it is imperative that allergists become more facile with their knowledge regarding these therapies.

You can earn up to 1.5 AMA PRA Category 1 Credits™, and up to 1.5 MOC Part II Self-Assessment credits. 

  • Efficacy and Safety of OIT and EPIT
    J. Andrew Bird, MD, FACAAI
  • Practical Impediments to These New Therapies
    Julie Wang, MD, FACAAI
  • Food Immunotherapy 2.0: What the Future May Hold
    Brian P. Vickery, MD

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.5 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Objective 1:
Differentiate OIT from EPIT in terms of efficacy and safety.

Objective 2:
Understand impediments for implementation of these therapies.

Objective 3:
Identify frequently asked questions regarding these therapies.

Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2019 Annual Meeting is available online and via the meeting app.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC
Course opens: 
Course expires: 

J. Andrew Bird, MD, FACAAI

Brian P. Vickery, MD

Julie Wang, MD, FACAAI

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC


Please login or create an account to take this course.